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Objective: With the increasing incidence of methicillin-resistant Staphylococcus au-
reus (MRSA) in hand infections in urban centers, multiple studies have recommended
using MRSA-effective antibiotics as ﬁrst-line treatment of hand infections. This study
assesses the effect of adopting this recommendation for the treatment of hand infections
at the authors’ hospital. Methods: Patients with hand infections drained in the authors’
hospital were prospectively enrolled in an observational study over a 12-month period.
Culture results and response to treatment were recorded. Results: Twenty-two patients
met inclusion criteria. Eleven of 14 patients with S aureus infections had MRSA. All
of these patients responded to the initial antibiotic selected. Two patients had infections
that did not respond to trimethoprim-sulfamethoxazole. One grew group A Streptococ-
cus infection, and the other had lymphangitic streaking that suggested Streptococcus
infection. Conclusion: Because of the high prevalence of MRSA among hand infec-
tions at the authors’ institution, we continue to prescribe MRSA-effective antibiotics as
ﬁrst-line treatment of hand abscesses. Close follow-up is still necessary to conﬁrm that
each patient has responded appropriately to treatment or to allow modiﬁcation of the
treatment plan if the patient has not responded to treatment.
Since the early reports of methicillin resistance in Staphylococcus aureus,1,2 there
has been great interest in monitoring its prevalence as an infecting organism. Multiple
recent reports have documented the increase in frequency of methicillin resistance among
S aureus taken from abscesses and other infections.3,4 Several reports in the past few
years have speciﬁcally documented the rise of methicillin-resistant S aureus (MRSA) in
community-acquired infections. Mechanisms of spread of methicillin resistance have also
been studied.5,6
Multiple recent reports have speciﬁcally focused on the increase of MRSA in hand
infections.7−11 These reports came out of major urban hospitals in Chicago and Dallas,
where the prevalence of MRSA in the community is high. These studies concluded that
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in communities where MRSA prevalence is high, strong consideration should be given to
choosing an antibiotic effective against MRSA as ﬁrst-line treatment of abscesses of the
hand after appropriate drainage.
The urban area surrounding the authors’ hospital also has a high MRSA prevalence
rate. On the basis of this and the above reports, our ER and hand services adopted the
recommendationsofthestudies7,9andbeganprescribingantibioticseffectiveagainstMRSA
as ﬁrst-line treatment for discharge after drainage of a hand infection in patients with no
known increased risk (such as diabetes mellitus and intravenous [IV] drug abuse) for
gram-negative infection. Based on low-cost and easier twice-a-day dosing, trimethoprim-
sulfamethoxazole (TMP-SMX) was selected as the preferred antibiotic, as it was in the
above studies.
Thepurposeofthisstudywastoprospectivelymonitortheresultsoftreatmentofhand
infections at the authors’ institution after adoption of TMP-SMX as ﬁrst-line treatment of
patients discharged from the ER after drainage of a hand abscess.
METHODS
Patients were collected prospectively from October 2007 to September 2008. All patients
with inﬂammation at or distal to the radiocarpal joint presenting to the Johns Hopkins
Bayview Medical Center emergency department were evaluated to determine whether
they were candidates for the study. Patients were drained in the emergency department or
operating room as deemed appropriate by the treating surgeon. Patients with no identiﬁable
ﬂuid collection to drain were admitted for IV antibiotics or discharged on oral antibiotics
depending on severity of inﬂammation and medical comorbidities. Patients who received
more than 24 hours of antibiotics (greater than 24 hours between initiation of antibiotic
therapy and identiﬁcation of a drainable ﬂuid collection) were excluded from the study.
All patients were managed with the standard treatment for hand infections. There was no
alteration in patient care practices due to study participation.
All ﬂuid collections drained were sent for culture and sensitivities. Patients were
given systemic antistaphylococcal antibiotics orally (if discharged from the ER) or intra-
venously (if admitted to the hospital). Because of the high frequency of MRSA in our
hospital and based on multiple previous studies (see the introductory paragraphs), IV van-
comycin and oral TMP-SMX double strength were used for all patients unless there was a
known allergy. Patients with allergies received clindamycin. Patients felt to be at increased
risk of gram-negative infection (diabetics, IV drug abusers, or history of cat or dog bite)
received broadened-spectrum antibiotic coverage (IV ampicillin/sulbactam or oral amox-
icillin/clavulonic acid, or a quinolone if penicillin allergic) in addition to coverage for
MRSA.
Patients were followed with serial examination. Patients admitted to the hospital were
reassessed at least once a day. Those sent home from the ER were instructed to follow-up
2 days later. Patients discharged from the ER who did not follow up within 72 hours would
have been excluded from the study, but this situation did not occur in our study population.
All patients received antibiotics for 7 to 10 days and local wound care to the drainage
site until resolution of inﬂammation. If culture and sensitivity information indicated, an-
tibiotic coverage was changed once this information became available.
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Table 1. Specimens (%) sensitive to the antibioticsa
Trimethoprim-
Oxacillin Clindamycin Erythromycin Ciproﬂoxacin Tetracycline sulfamethoxazole
MRSAb 0 82 27 0 92 100
MSSAc 100 100 100 100 100 100
aMRSA indicates methicillin-resistant Staphylococcus aureus.
bThere were 11 specimens in this group.
cThere were 3 specimens in this group.
This study was approved by the Johns Hopkins Medical Institutions investigational
review board (IRB ﬁle number: NA 00011969).
RESULTS
Twenty-two patients met inclusion criteria. As with previous studies, our study showed a
high prevalence of MRSA. Eleven of 14 Staphylococcus cultures were methicillin resistant.
Sensitivities of Staphylococcus are shown in Table 1. All MRSA cultures were sensitive to
TMP-SMX, but sensitivity to other antibiotics was highly variable, ranging from 27% to
92%.
One patient’s cultures grew out Pseudomonas species. This patient had a history of IV
drugabuse.Onepatient,witharecenthistoryofcatbite,grewPasteurellafromhercultures.
Both of these gram-negative rods were sensitive to quinolones, aminoglycosides, and anti-
pseudomonnal penicillins and cephalosporins. Both patients had signiﬁcant inﬂammation
at the time of presentation and were admitted to the hospital after drainage. Both patients
receivedIVvancomycinandpiperacillin-tazobactamuntilsensitivitieswereavailable.Both
patients were discharged on oral levoﬂoxacin. They were followed up in clinic and their
wounds and inﬂammation went on to resolve without further intervention.
We also identiﬁed one patient who grew out group A Streptococcus species from
their cultures. The patient did not demonstrate lymphangitic streaking during the initial ER
visit. The patient had been drained in the emergency department and discharged. Follow-
up in the ofﬁce 2 days after drainage (coinciding with when culture and sensitivity results
becameavailable)demonstratedpersistentinﬂammation(minimallyimprovedfrompriorto
drainage)butnoresidualpurulence.ThepatienthadbeendischargedonoralTMP-SMXDS
perourstandardtreatmentprotocol.Antibioticsforthispatientwerechangedtoamoxicillin-
clavulonicacid.Whenthispatientwasseeninfollow-upanadditional2dayslater,amarked
improvement of the inﬂammation was noted. A second patient had a similar clinical history
to the above patient, but his culture ultimately came back with no growth. He had been
discharged from the ER on oral TMP-SMX DS. At the time of the clinic visit, there was
persistentinﬂammationandquestionablelymphangiticstreaking,butnoresidualﬂuctuance
to allow for a new culture to be obtained. Based on this information and our experience
with the previous patient who grew out group A Streptococcus, we changed antibiotics to
amoxicillin/clavulonic acid. Two days later, the inﬂammation and lymphangitic streaking
were markedly improved, and inﬂammation was resolved an additional week later. We
suspected that this patient, despite the negative culture, may also have had TMP-SMX-
resistant Streptococcus. For both of these patients, the drainage incisions went on to heal
with no residual inﬂammation by the next follow-up visit 1 week later.
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DISCUSSION
Multiple previous studies have documented the increasing frequency of MRSA cultures
for infections of the hand and other locations.3,4,7−9 Reasons for this increase have been
proposed.5,6 Many of these studies concluded that antibiotics effective against MRSA
should be selected as ﬁrst-line treatment of patients with infections in which S aureus is
considered likely to be a pathogen.
The authors’ hospital antibiogram shows a high prevalence of MRSA. For this reason,
the recommendations of the above studies were adopted. Anti-MRSA medications were
selected as primary treatment of community-acquired hand infections. This study reviews
ourexperiencewiththetreatmentofhandinfectionssincetheadoptionofthispolicy.While
patients with signiﬁcant comorbidities and those admitted to the hospital were covered
with broad spectrum antimicrobials, those patients discharged from the ER were routinely
prescribed TMP-SMX DS alone. The 2 patients, whose cultures grew gram-negative rods
(onePseudomonas,onePasteurella),wereadmittedbecauseoftheseverityofinﬂammation
surrounding the abscess as well as for signiﬁcant comorbidities that raised our suspicion
for gram-negative infection (one was an IV drug abuser and the other presented 2 days
after a cat bite). As such, they were covered from the time of admission with antimicrobials
effective against the pathogen in their abscesses. The one patient with Streptococcus and
the second patient with suspected Streptococcus had been sent home on TMP-SMX as
described above. They ultimately required treatment with amoxicillin-clavulonic acid to
resolve inﬂammation. Although these 2 patients had a slight delay in resolution of their
symptoms due to selection of an anti-MRSA medication that was not effective against the
Streptococcus that ultimately grew out in culture for one and was suspected on the basis
of the clinical course of the other, given the continued high prevalence of MRSA in our
community, our practice has continued to recommend MRSA-effective antibiotics as initial
treatment of patient presenting with community-acquired hand infections.
ForcommunitieswhereMRSAprevalenceishigh,TMP-SMXremainsagoodempiric
choice for hand infections. For those patients who do not respond to TMP-SMX or who
show ﬁndings suggestive of Streptococcus infections, additional coverage with a better
antistreptococcal medication such as amoxicillin-clavulonic acid is a reasonable option. A
ﬁrst-generation cephalosporin such as cephalexin is also a reasonable alternative but may
increase risk of noncompliance due to 4 times per day dosing.
MRSA samples in our patients were also highly sensitive to clindamycin (82%) and
tetracycline (92%). Clindamycin may be less likely to fail patients with Streptococcus
infection but does carry a higher risk of antibiotic-associated diarrhea, higher cost, and
higher risk of noncompliance due to QID dosing. Tetracycline family medicines such
as doxycycline could be used as well, but it also carries a risk failure in Streptococcus
infections as well as a risk of allergy.
For any hospital setting, the choice of antimicrobial treatment of patients who undergo
drainage of a hand infection must be based on a number of factors: hospital/community
prevalence of MRSA, patient comorbidities, and ability/likelihood of the patient to comply
with antibiotic regimens requiring multiple doses per day.
Our study is limited by its small patient number. However, on the basis of our results,
wecontinuetotreathandinfectionswithdrainableabscesseswithvancomycin(ifadmitted)
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or TMP-SMX DS (if discharged from the ER) as primary therapy. Failures of this treatment
algorithm continue to be uncommon.
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